candesartan has been researched along with Extravasation of Contrast Media in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with candesartan increased EB extravasation in the kidney in normovolaemic controls." | 1.33 | Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats. ( Binkowski, K; Dendorfer, A; Eichler, W; Klotz, KF; Puchakayala, MR; Schumacher, J, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schumacher, J | 1 |
Puchakayala, MR | 1 |
Binkowski, K | 1 |
Eichler, W | 1 |
Dendorfer, A | 1 |
Klotz, KF | 1 |
1 other study available for candesartan and Extravasation of Contrast Media
Article | Year |
---|---|
Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimid | 2006 |